Editing Craig Venter (section)

===Human Longevity, Inc.===
On March 4, 2014, Venter and co-founders [[Peter Diamandis]] and Robert Hariri announced the formation of [[Human Longevity]], Inc., a company focused on extending the healthy, "high performance" human lifespan.<ref name="Human Longevity Inc-2014">{{cite news | title = Human Longevity Inc. (HLI) Launched to Promote Healthy Aging Using Advances in Genomics and Stem Cell Therapies | publisher = [[PR Newswire]] | date = March 4, 2014 | url = http://www.prnewswire.com/news-releases/human-longevity-inc-hli-launched-to-promote-healthy-aging-using-advances-in-genomics-and-stem-cell-therapies-248379091.html | access-date = December 16, 2014 | archive-url = https://web.archive.org/web/20141021000819/http://www.prnewswire.com/news-releases/human-longevity-inc-hli-launched-to-promote-healthy-aging-using-advances-in-genomics-and-stem-cell-therapies-248379091.html | archive-date = October 21, 2014 | url-status = dead }}</ref><ref name="Bigelow-2014">{{cite news | last = Bigelow | first = Bruce V.  | title = Craig Venter's Latest Startup Gets $70M To Sequence Loads of Genomes | publisher = [[Xconomy]] | date = March 4, 2014 | url = http://www.xconomy.com/san-diego/2014/03/04/craig-venters-latest-startup-gets-70m-to-sequence-loads-of-genomes/ | access-date = December 16, 2014 }}</ref> At the time of the announcement the company had already raised $70&nbsp;million in [[Venture capital financing|venture financing]], which was expected to last 18&nbsp;months.<ref name="Human Longevity Inc-2014" /><ref name="Bigelow-2014" /> Venter served as the chairman and chief executive officer&nbsp;(CEO) until May 2018, when he retired. The company said that it plans to sequence 40,000 genomes per year, with an initial focus on [[Cancer genome sequencing|cancer genomes]] and the genomes of cancer patients.<ref name="Human Longevity Inc-2014" />

Human Longevity filed a lawsuit in 2018 against Venter, accusing him of stealing trade secrets. Allegations were made stating that Venter had departed with his company computer that contained valuable information that could be used to start a competing business.<ref>{{Cite web|title=Genomics Company Human Longevity Sues J. Craig Venter Institute|url=https://www.the-scientist.com/news-opinion/genomics-company-human-longevity-sues-j--craig-venter-institute-64539|access-date=October 23, 2020|website=[[The Scientist (magazine)|The Scientist]]}}</ref> The lawsuit was ultimately dismissed by a California judge on the basis that Human Longevity were unable to present a case that met the legal threshold required for a company, or individual, to sue when its trade secrets have been stolen.<ref>{{Cite web|url=https://www.statnews.com/2018/12/19/judge-dismisses-lawsuit-accusing-craig-venter-of-stealing-trade-secrets/|title=Judge dismisses lawsuit accusing Craig Venter of stealing trade secrets|date=December 19, 2018|website=STAT|language=en-US|access-date=April 3, 2020}}</ref>

Human Longevity's mission is to extend healthy human lifespan by the use of high-resolution [[big data]] diagnostics from [[genomics]], [[Metabolome|metabolomics]], [[Microbiome|microbiomics]], and [[proteomics]], and the use of [[stem cell therapy]].<ref name="Smith-2014">{{cite news | last = Smith | first = Robin L.  | title = The Regeneration Generation: A Conversation With Bob Hariri, Vice-Chairman and Co-Founder of Human Longevity Inc. | work = [[The Huffington Post]] | date = November 11, 2014 | url = https://www.huffingtonpost.com/robin-l-smith/the-regeneration-generati_b_6199076.html | access-date = December 16, 2014 }}</ref>